- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 531.97K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 531.97K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 7.12K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.88M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.89M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $61.87K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.55M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.55M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.17M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.36M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.99M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.42M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$4.18 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$240.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$4.18 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$240.07 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.53M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.64M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $749.81K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $75.53K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.22M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.71M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.72M |